TAP has had an extraordinary history of growth and financial performance. Both Prevacid® (lansoprazole) and Lupron Depot® (leuprolide acetate for depot suspension) are leading drugs in their classes and rank among the top-selling drugs overall in the United States. We take pride in our success. But we know that to reach our potential, we must remain connected to the care of patients. We look forward to a long and successful future as we search for new ways to help patients through our mission to produce life-enhancing products. 
For more information, visit our parent company Web sites: |
 |
